Background And Research Objective: There are different care and treatment approaches to prevent femoral arteriotomy complications and contrast nephropathy in patients undergoing cardiac catheterization. The purpose of our study was to identify approaches widely used in Turkey to prevent femoral arteriotomy complications and contrast nephropathy in patients undergoing cardiac catheterization.

Materials And Methods: The study was a descriptive study. A questionnaire was mailed to 36 university medical faculty hospitals that have active interventional cardiology units. Twenty-nine universities (80.5%) responded.

Results And Conclusions: In general in Turkey, only manual pressure is used to achieve initial hemostasis at the femoral insertion site, with a pressure dressing and sandbag added to maintain hemostasis. Arterial closure devices are rarely used. In general, after the procedure, patients are required to lie flat with, at most, a 15- to 30-degree elevation during bed rest. To prevent contrast nephropathy in patients at risk, intravenous saline solutions are started before the procedure and continued afterward. In other patients, only oral fluid replacement is used. Traditional approaches in the management of femoral artery insertion site continue, and practices used in the prevention of contrast nephropathy are similar to current practices.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JCN.0000297389.03700.51DOI Listing

Publication Analysis

Top Keywords

contrast nephropathy
20
nephropathy patients
16
prevent femoral
12
femoral arteriotomy
12
arteriotomy complications
12
complications contrast
12
patients undergoing
12
undergoing cardiac
12
cardiac catheterization
12
approaches turkey
8

Similar Publications

Chemiluminescent Probe for Enhanced Visualization of Renal Ischemia-Reperfusion Injury via Pyroglutamate Aminopeptidase-1 Activation.

Anal Chem

January 2025

Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.

The absence of an effective imaging tool for diagnosing renal ischemia-reperfusion injury (RIRI) severely delays its treatment, and currently, no definitive clinical interventions are available. Pyroglutamate aminopeptidase-1 (PGP-1), a potential inflammatory cytokine, has shown considerable potential as a biomarker for tracing the inflammatory process in vivo. However, its exact role in the enhanced visualization of RIRI in complex biological systems has yet to be fully established.

View Article and Find Full Text PDF

Polycystic kidney diseases (PKD) are genetic disorders which disrupt kidney architecture and function. Autosomal recessive PKD (ARPKD) is a rare form of PKD, caused by mutations in PKHD1, and clinically more severe than the more common autosomal dominant PKD (ADPKD). Prior studies have implicated Hedgehog (Hh) signaling in ADPKD, with increased levels of Hh components in experimental ADPKD and reduced cystogenesis following pharmacological Hh inhibition.

View Article and Find Full Text PDF

Contrast-induced acute kidney injury is a common complication marked by reduced kidney function within 48  hours of contrast administration. The aim of this study was to evaluate renal function, anatomy, and molecular changes at 24  hours, 48  hours, and 72  hours post-iodinated contrast media (ICM) administration. This true-experimental study used a post-test-only control group design.

View Article and Find Full Text PDF

Elevated Septal Native T1 Time in CMR Imaging Suggesting Myocardial Fibrosis in Young Kidney Transplant Recipients.

J Cardiovasc Magn Reson

January 2025

Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Electronic address:

Background: Patients after kidney transplantation (KTx) in childhood show a high prevalence of cardiac complications, but the underlying mechanism is still poorly understood. In adults, myocardial fibrosis detected in cardiac magnetic resonance (CMR) imaging is already an established risk factor. Data for children after KTx are not available.

View Article and Find Full Text PDF

Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies.

Kidney Int Rep

January 2025

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Introduction: Little is known regarding the comparison of cardiovascular and kidney outcomes between lupus nephritis (LN) and other etiologies of chronic kidney disease (CKD).

Methods: Using data from the Swedish Renal Registry (2006-2021), we compared long-term outcomes between patients with LN-CKD and patients with CKD due to primary glomerular diseases (PGD) and other CKD causes (Other-CKD, mainly diabetes and nephroangiosclerosis). Adjusted hazard ratios (HRs) of mortality, major adverse cardiovascular events (MACE) and kidney replacement therapy (KRT) were estimated using Cox proportional hazard models.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!